tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Molecular Partners price target lowered to $4 from $4.50 at JPMorgan
The FlyMolecular Partners price target lowered to $4 from $4.50 at JPMorgan
6d ago
MOLN
Molecular Partners: Promising Pipeline and Financial Stability Justify Buy Rating Despite IND Delay
PremiumRatings
Molecular Partners: Promising Pipeline and Financial Stability Justify Buy Rating Despite IND Delay
12d ago
MOLN
Promising Developments and Strategic Resource Management Justify Buy Rating for Molecular Partners AG
PremiumRatings
Promising Developments and Strategic Resource Management Justify Buy Rating for Molecular Partners AG
13d ago
MOLN
Molecular Partners Reports H1 2025 Progress and Financial Stability
PremiumCompany Announcements
Molecular Partners Reports H1 2025 Progress and Financial Stability
14d ago
Molecular Partners’ Promising Pipeline and Strategic Advancements Justify Buy Rating
PremiumRatings
Molecular Partners’ Promising Pipeline and Strategic Advancements Justify Buy Rating
14d ago
MOLN
Molecular Partners appoints Martin Steegmaier as chief scientific officer
PremiumThe FlyMolecular Partners appoints Martin Steegmaier as chief scientific officer
19d ago
MOLN
Molecular Partners’ Promising Oncology Developments and Strategic Focus Earn Buy Rating
Premium
Ratings
Molecular Partners’ Promising Oncology Developments and Strategic Focus Earn Buy Rating
3M ago
MOLN
Buy Recommendation for Molecular Partners: Promising MP0533 Study Results and Strategic Developments
Premium
Ratings
Buy Recommendation for Molecular Partners: Promising MP0533 Study Results and Strategic Developments
3M ago
MOLN
Molecular Partners to preent updated data from MP0533 trial at EHA congress
PremiumThe Fly
Molecular Partners to preent updated data from MP0533 trial at EHA congress
3M ago
MOLN
Molecular Partners: Strategic Restructuring and Financial Stability Drive Buy Rating
PremiumRatings
Molecular Partners: Strategic Restructuring and Financial Stability Drive Buy Rating
3M ago
MOLN
Molecular Partners to reduce workforce by 24%
PremiumThe Fly
Molecular Partners to reduce workforce by 24%
3M ago
MOLN
Molecular Partners’ Strategic Advancements and Promising Pipeline Drive Buy Rating
PremiumRatings
Molecular Partners’ Strategic Advancements and Promising Pipeline Drive Buy Rating
4M ago
MOLN
Molecular Partners’ Promising MP0533 Program Drives Buy Recommendation
PremiumRatingsMolecular Partners’ Promising MP0533 Program Drives Buy Recommendation
4M ago
MOLN
Molecular Partners presents new data on Radio-DARPin, Switch-DARPin programs
Premium
The Fly
Molecular Partners presents new data on Radio-DARPin, Switch-DARPin programs
5M ago
MOLN
Molecular Partners: Strategic Positioning and Innovative Platforms Drive Buy Rating in Oncology Space
Premium
Ratings
Molecular Partners: Strategic Positioning and Innovative Platforms Drive Buy Rating in Oncology Space
6M ago
MOLN
Molecular Partners initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Molecular Partners initiated with an Outperform at LifeSci Capital
6M ago
MOLN
Molecular Partners’ Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Molecular Partners’ Earnings Call: Progress Amid Challenges
6M ago
Molecular Partners AG: Strong Financials and Promising Pipeline Justify Buy Rating
PremiumRatings
Molecular Partners AG: Strong Financials and Promising Pipeline Justify Buy Rating
6M ago
MOLN
Molecular Partners Reports 2024 Earnings and Strategic Progress
PremiumCompany Announcements
Molecular Partners Reports 2024 Earnings and Strategic Progress
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >